DR. BARRY L GRUBER M.D. NPI 1710912431

NPI Information

  • NPI: 1710912431
  • Provider Name: DR. BARRY L GRUBER, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 500 W MAIN ST
    SUITE 110
    BABYLON, NY
    ZIP 11702
  • Phone: (631) 376-2663

Map and Directions

Get Directions

NPI Details

DR. Barry L Gruber, M.D. is a rheumatology internal medicine in Babylon, NY with 46 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Barry L Gruber, M.D. NPI is 1710912431. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK MEDICAL COLLEGE
Graduation Year:1979

The provider's business location address is:

500 W MAIN ST
SUITE 110
BABYLON, NY
ZIP 11702-027
Phone: (631) 376-2663
Fax: (631) 376-4800

The NPI 1710912431 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg (HCPCS:J3304)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • 5% dextrose/water (500 ml = 1 unit) (HCPCS:J7060)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • X-ray of thigh bone, 1 view (HCPCS:73551)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Ultrasonic guidance for needle placement (HCPCS:76942)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Injection into tendon or ligament (HCPCS:20550)
  • Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
  • Injection of carpal tunnel (HCPCS:20526)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 7/11/2006 and was last updated on 6/16/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatology145236NEW YORKYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
100825452MEDICAIDNEW YORK
21666152OTHERNEW YORKAETNA
3WZVQP1MEDICARE PINNEW YORK
4CS396OTHERNEW YORKOXFORD
54739F1OTHERNEW YORKBC/BS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.